Abstract
Since 2001, the association of CCR7 expression by tumor cells with LN metastasis (and associated poor clinical outcome) has been validated in a large number of solid tumors as well as in hematopoietic malignancies. Local factors such as hypoxia, cytokines (endothelins), or epigenetic changes may be involved in the upregulation of CCR7 by tumor cells. Through distinct signaling pathways, activation of CCR7 by its cognate ligands, CCL21 or CCL19, promotes migration, invasion and proliferation of tumor cells in vitro. In addition to responding to exogenous sources of CCR7 ligands, CCR7-expressing tumor cells facilitate their own migration towards CCL21-expressing lymphatics by generating transcellular gradients of CCL19/21. While CCR7 antagonists appear to block LN metastasis in short-term experimental models, the dual roles of CCR7 in protective immunity and tolerance suggests that these agents must be carefully evaluated. Meanwhile, increasing CCR7 expression in DCs may represent a potentially useful means of improving the efficacy of in vivo DC vaccination strategies.
Keywords
- Esophageal Squamous Cell Carcinoma
- Oropharyngeal Squamous Cell Carcinoma
- Intratumoral Lymphatic Vessel
- Adoptive Cell Transfer Therapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sanchez-Sanchez, N., L. Riol-Blanco, and J. L. Rodriguez-Fernandez. 2006. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176:5153–5159.
Saeki, H., A. M. Moore, M. J. Brown, and S. T. Hwang. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol 162:2472–2475.
Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23–33.
Schneider, M. A., J. G. Meingassner, M. Lipp, H. D. Moore, and A. Rot. 2007. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. The Journal of experimental medicine 204:735–745.
Worbs, T., and R. Forster. 2007. A key role for CCR7 in establishing central and peripheral tolerance. Trends Immunol 28:274–280.
Yoshida, R., M. Nagira, M. Kitaura, N. Imagawa, T. Imai, and O. Yoshie. 1998. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 273:7118–7122.
Nagira, M., T. Imai, K. Hieshima, J. Kusuda, M. Ridanpaa, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie. 1997. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem 272:19518–19524.
Hedrick, J. A., and A. Zlotnik. 1997. Identification and characterization of a novel beta chemokine containing six conserved cysteines. J Immunol 159:1589–1593.
Gunn, M. D., K. Tangemann, C. Tam, J. G. Cyster, S. D. Rosen, and L. T. Williams. 1998. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 95:258–263.
Yoshida, R., T. Imai, K. Hieshima, J. Kusuda, M. Baba, M. Kitaura, M. Nishimura, M. Kakizaki, H. Nomiyama, and O. Yoshie. 1997. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272:13803–13809.
Rossi, D. L., A. P. Vicari, K. Franz-Bacon, T. K. McClanahan, and A. Zlotnik. 1997. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Immunol 158:1033–1036.
Ngo, V. N., H. L. Tang, and J. G. Cyster. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 188:181–191.
Sallusto, F., D. Lenig, R. Forster, M. Lipp, A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708–712.
Campbell, J. J., J. Hedrick, A. Zlotnik, M. A. Siani, D. A. Thompson, and E. C. Butcher. 1998. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279:381–384.
Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189:451–460.
Ziegler, E., F. Gueler, S. Rong, M. Mengel, O. Witzke, A. Kribben, H. Haller, U. Kunzendorf, and S. Krautwald. 2006. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking. J Am Soc Nephrol 17:2521–2532.
Ziegler, E., M. Oberbarnscheidt, S. Bulfone-Paus, R. Forster, U. Kunzendorf, and S. Krautwald. 2007. CCR7 signaling inhibits T cell proliferation. J Immunol 179:6485–6493.
Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui, and A. Zlotnik. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56.
Kakinuma, T., and S. T. Hwang. 2006. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79:639–651.
Wiley, H. E., E. B. Gonzalez, W. Maki, M. T. Wu, and S. T. Hwang. 2001. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93:1638–1643.
Cabioglu, N., M. S. Yazici, B. Arun, K. R. Broglio, G. N. Hortobagyi, J. E. Price, and A. Sahin. 2005. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 11:5686–5693.
Kodama, J., Hasengaowa, T. Kusumoto, N. Seki, T. Matsuo, Y. Ojima, K. Nakamura, A. Hongo, and Y. Hiramatsu. 2007. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Ann Oncol 18:70–76.
Takeuchi, H., A. Fujimoto, M. Tanaka, T. Yamano, E. Hsueh, and D. S. Hoon. 2004. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10:2351–2358.
Gunther, K., J. Leier, G. Henning, A. Dimmler, R. Weissbach, W. Hohenberger, and R. Forster. 2005. Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7. Int J Cancer 116:726–733.
Ishigami, S., S. Natsugoe, A. Nakajo, K. Tokuda, Y. Uenosono, T. Arigami, M. Matsumoto, H. Okumura, S. Hokita, and T. Aikou. 2007. Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology 54:1025–1028.
Yan, C., Z. G. Zhu, Y. Y. Yu, J. Ji, Y. Zhang, Y. B. Ji, M. Yan, J. Chen, B. Y. Liu, H. R. Yin, and Y. Z. Lin. 2004. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World J Gastroenterol 10:783–790.
Tsuzuki, H., N. Takahashi, A. Kojima, N. Narita, H. Sunaga, T. Takabayashi, and S. Fujieda. 2006. Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. Auris Nasus Larynx 33:37–42.
Pitkin, L., S. Luangdilok, C. Corbishley, P. O. Wilson, P. Dalton, D. Bray, S. Mady, P. Williamson, T. Odutoye, P. Rhys Evans, K. N. Syrigos, C. M. Nutting, Y. Barbachano, S. Eccles, and K. J. Harrington. 2007. Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival. Br J Cancer 97:670–677.
Ding, Y., Y. Shimada, M. Maeda, A. Kawabe, J. Kaganoi, I. Komoto, Y. Hashimoto, M. Miyake, H. Hashida, and M. Imamura. 2003. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9:3406–3412.
Wang, J., L. Xi, J. L. Hunt, W. Gooding, T. L. Whiteside, Z. Chen, T. E. Godfrey, and R. L. Ferris. 2004. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 64:1861–1866.
Sancho, M., J. M. Vieira, C. Casalou, M. Mesquita, T. Pereira, B. M. Cavaco, S. Dias, and V. Leite. 2006. Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol 191:229–238.
Takanami, I. 2003. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105:186–189.
Schimanski, C. C., R. Bahre, I. Gockel, T. Junginger, N. Simiantonaki, S. Biesterfeld, T. Achenbach, T. Wehler, P. R. Galle, and M. Moehler. 2006. Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer. Oncol Rep 16:109–113.
Heresi, G. A., J. Wang, R. Taichman, J. A. Chirinos, J. J. Regalado, D. M. Lichtstein, and J. D. Rosenblatt. 2005. Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression. Urol Oncol 23:261–267.
Hasegawa, H., T. Nomura, M. Kohno, N. Tateishi, Y. Suzuki, N. Maeda, R. Fujisawa, O. Yoshie, and S. Fujita. 2000. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 95:30–38.
Till, K. J., K. Lin, M. Zuzel, and J. C. Cawley. 2002. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99:2977–2984.
Lopez-Giral, S., N. E. Quintana, M. Cabrerizo, M. Alfonso-Perez, M. Sala-Valdes, V. G. De Soria, J. M. Fernandez-Ranada, E. Fernandez-Ruiz, and C. Munoz. 2004. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 76:462–471.
Lau, S. K., P. C. Boutros, M. Pintilie, F. H. Blackhall, C. Q. Zhu, D. Strumpf, M. R. Johnston, G. Darling, S. Keshavjee, T. K. Waddell, N. Liu, D. Lau, L. Z. Penn, F. A. Shepherd, I. Jurisica, S. D. Der, and M. S. Tsao. 2007. Three-gene prognostic classifier for early-stage non small-cell lung cancer. J Clin Oncol 25:5562–5569.
Andre, F., N. Cabioglu, H. Assi, J. C. Sabourin, S. Delaloge, A. Sahin, K. Broglio, J. P. Spano, C. Combadiere, C. Bucana, J. C. Soria, and M. Cristofanilli. 2006. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 17:945–951.
Wilson, J. L., J. Burchell, and M. J. Grimshaw. 2006. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1. Cancer Res 66:11802–11807.
Kedzierski, R. M., and M. Yanagisawa. 2001. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851–876.
Alanen, K., D. X. Deng, and S. Chakrabarti. 2000. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology 36:161–167.
Grimshaw, M. J., T. Hagemann, A. Ayhan, C. E. Gillett, C. Binder, and F. R. Balkwill. 2004. A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 64:2461–2468.
Grimshaw, M. J. 2005. Endothelins in breast tumour cell invasion. Cancer Lett 222:129–138.
Mori, T., J. Kim, T. Yamano, H. Takeuchi, S. Huang, N. Umetani, K. Koyanagi, and D. S. Hoon. 2005. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 65:1800–1807.
Kelly, W. K., O. A. O'Connor, and P. A. Marks. 2002. Histone deacetylase inhibitors: from target to clinical trials. Expert Opin Investig Drugs 11:1695–1713.
Dowell, J. E., and J. D. Minna. 2004. Cancer chemotherapy targeted at reactivating the expression of epigenetically inactivated genes. J Clin Oncol 22:1353–1355.
Marinissen, M. J., and J. S. Gutkind. 2001. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22:368–376.
Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5:546–559.
Verschueren, H., I. Van der Taelen, J. Dewit, J. De Braekeleer, and P. De Baetselier. 1994. Metastatic competence of BW5147 T-lymphoma cell lines is correlated with in vitro invasiveness, motility and F-actin content. J Leukoc Biol 55:552–556.
Wang, J., X. Zhang, S. M. Thomas, J. R. Grandis, A. Wells, Z. G. Chen, and R. L. Ferris. 2005. Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24:5897–5904.
Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565–568.
Cardones, A. R., T. Murakami, and S. T. Hwang. 2003. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta (1) integrin. Cancer Res 63:6751–6757.
Overall, C. M., and C. Lopez-Otin. 2002. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–672.
Koizumi, K., Y. Kozawa, Y. Ohashi, E. S. Nakamura, Y. Aozuka, H. Sakurai, K. Ichiki, Y. Doki, T. Misaki, and I. Saiki. 2007. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep 17:1511–1516.
Redondo-Munoz, J., M. Jose Terol, J. A. Garcia-Marco, and A. Garcia-Pardo. 2008. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 111:383–386.
Murakami, T., A. R. Cardones, S. E. Finkelstein, N. P. Restifo, B. A. Klaunberg, F. O. Nestle, S. S. Castillo, P. A. Dennis, and S. T. Hwang. 2003. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198:1337–1347.
Fang, L., V. Lee, E.Cha, H. Zhang, and S. T. Hwang. 2008. CCR7 regulates B16 murine melanoma cell tumorigenesis in skin. J. Leukou Biol 84(4):965–72.
Kriehuber, E., S. Breiteneder-Geleff, M. Groeger, A. Soleiman, S. F. Schoppmann, G. Stingl, D. Kerjaschki, and D. Maurer. 2001. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 194:797–808.
Lee, C. H., T. Kakinuma, J. Wang, H. Zhang, D. C. Palmer, N. P. Restifo, and S. T. Hwang. 2006. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol Cancer Ther 5:2592–2599.
Shields, J. D., M. S. Emmett, D. B. Dunn, K. D. Joory, L. M. Sage, H. Rigby, P. S. Mortimer, A. Orlando, J. R. Levick, and D. O. Bates. 2007. Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene 26:2997–3005.
Skobe, M., T. Hawighorst, D. G. Jackson, R. Prevo, L. Janes, P. Velasco, L. Riccardi, K. Alitalo, K. Claffey, and M. Detmar. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192–198.
Stacker, S. A., C. Caesar, M. E. Baldwin, G. E. Thornton, R. A. Williams, R. Prevo, D. G. Jackson, S. Nishikawa, H. Kubo, and M. G. Achen. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186–191.
Mandriota, S. J., L. Jussila, M. Jeltsch, A. Compagni, D. Baetens, R. Prevo, S. Banerji, J. Huarte, R. Montesano, D. G. Jackson, L. Orci, K. Alitalo, G. Christofori, and M. S. Pepper. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672–682.
He, Y., I. Rajantie, K. Pajusola, M. Jeltsch, T. Holopainen, S. Yla-Herttuala, T. Harding, K. Jooss, T. Takahashi, and K. Alitalo. 2005. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65:4739–4746.
Dadras, S. S., T. Paul, J. Bertoncini, L. F. Brown, A. Muzikansky, D. G. Jackson, U. Ellwanger, C. Garbe, M. C. Mihm, and M. Detmar. 2003. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951–1960.
Shields, J. D., M. Borsetti, H. Rigby, S. J. Harper, P. S. Mortimer, J. R. Levick, A. Orlando, and D. O. Bates. 2004. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 90:693–700.
Williams, C. S., R. D. Leek, A. M. Robson, S. Banerji, R. Prevo, A. L. Harris, and D. G. Jackson. 2003. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200:195–206.
Sipos, B., M. Kojima, K. Tiemann, W. Klapper, M. L. Kruse, H. Kalthoff, B. Schniewind, J. Tepel, H. Weich, D. Kerjaschki, and G. Kloppel. 2005. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 207:301–312.
Wong, S. Y., H. Haack, D. Crowley, M. Barry, R. T. Bronson, and R. O. Hynes. 2005. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 65:9789–9798.
Shields, J. D., M. E. Fleury, C. Yong, A. A. Tomei, G. J. Randolph, and M. A. Swartz. 2007. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11:526–538.
Lanzavecchia, A., and F. Sallusto. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2:982–987.
Gattinoni, L., C. A. Klebanoff, D. C. Palmer, C. Wrzesinski, K. Kerstann, Z. Yu, S. E. Finkelstein, M. R. Theoret, S. A. Rosenberg, and N. P. Restifo. 2005. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest 115:1616–1626.
Kim, J. W., R. L. Ferris, and T. L. Whiteside. 2005. Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis. Clin Cancer Res 11:7901–7910.
Dudley, M. E., J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula, D. E. White, S. A. Mavroukakis, L. J. Rogers, G. J. Gracia, S. A. Jones, D. P. Mangiameli, M. M. Pelletier, J. Gea-Banacloche, M. R. Robinson, D. M. Berman, A. C. Filie, A. Abati, and S. A. Rosenberg. 2005. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23:2346–2357.
Powell, D. J., Jr., M. E. Dudley, P. F. Robbins, and S. A. Rosenberg. 2005. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood 105:241–250.
Gilboa, E. 2007. DC-based cancer vaccines. J Clin Invest 117:1195–1203.
Sanchez-Sanchez, N., L. Riol-Blanco, G. de la Rosa, A. Puig-Kroger, J. Garcia-Bordas, D. Martin, N. Longo, A. Cuadrado, C. Cabanas, A. L. Corbi, P. Sanchez-Mateos, and J. L. Rodriguez-Fernandez. 2004. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104:619–625.
Morse, M. A., R. E. Coleman, G. Akabani, N. Niehaus, D. Coleman, and H. K. Lyerly. 1999. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res 59:56–58.
Okada, N., N. Mori, R. Koretomo, Y. Okada, T. Nakayama, O. Yoshie, H. Mizuguchi, T. Hayakawa, S. Nakagawa, T. Mayumi, T. Fujita, and A. Yamamoto. 2005. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction. Gene Ther 12:129–139.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fang, L., Hwang, S.T. (2009). Roles for CCR7 in Cancer Biology. In: Fulton, A. (eds) Chemokine Receptors in Cancer. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60327-267-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-60327-267-4_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-266-7
Online ISBN: 978-1-60327-267-4
eBook Packages: MedicineMedicine (R0)